Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease

BACKGROUND: The analysis of plasma cell-free DNA (cfDNA) is expected to provide useful biomarkers for early diagnosis of non-small-cell lung cancer (NSCLC). However, it remains unclear whether the intense release of cfDNA into the bloodstream of NSCLC patients results from malignancy or chronic infl...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Br J Cancer
Main Authors: Szpechcinski, A, Chorostowska-Wynimko, J, Struniawski, R, Kupis, W, Rudzinski, P, Langfort, R, Puscinska, E, Bielen, P, Sliwinski, P, Orlowski, T
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2015
Assuntos:
Molecular Diagnostics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4522634/
https://ncbi.nlm.nih.gov/pubmed/26125447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.225
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares